ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly net cash paid for acquisitions ($M) [legacy through FY2022] ($M)
Annual figures from Eli Lilly's filings and investor materials
Latest, FY2022
327
Period ended Dec 31, 2022
Change on a year earlier
-56.2%
747 in FY2021
History
16 years
Since FY2007
Sources
14
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net cash paid for acquisitions ($M) [legacy through FY2022] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Dec 31, 2022 | 327 | -56.2% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 747 | -12.0% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 849 | -87.7% | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 6,918 | – | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | -0 | -100.0% | Form 10-K (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 882 | +1,860.2% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 45 | -99.1% | Form 10-K (filed 2017-02-21) ↗ |
| FY2015 | Dec 31, 2015 | 5,283 | +858.1% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 551 | +1,161.8% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 43.7 | -78.1% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 199 | -35.3% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 308 | -49.5% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | 609 | – | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | -0 | -100.0% | Form 10-K (filed 2010-02-22) ↗ |
| FY2008 | Dec 31, 2008 | 6,083 | +127.6% | Form 10-K (filed 2010-02-22) ↗ |
| FY2007 | Dec 31, 2007 | 2,673 | – | Form 10-K (filed 2010-02-22) ↗ |
Cite this data
StockData. (2026). Eli Lilly Net cash paid for acquisitions ($M) [legacy through FY2022] ($M), annual FY2007–FY2022 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_acq_cf
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.